New Customer Mounjaro Pricing With £40 First Order Discount
First Order Mounjaro Prices - £40 Off Applied
As a new EverydayMeds customer, you'll pay significantly less for your first Mounjaro prescription. Compare these first-order prices with £40 discount already applied: 2.5mg starter pen £129.99 (regular £169.99), 5mg pen £159.99 (regular £199.99), 7.5mg pen £209.99 (regular £249.99), and 10mg pen £229.99 (regular £269.99). Higher maintenance doses: 12.5mg £259.99 (regular £299.99) and 15mg £278.99 (regular £318.99).
Getting Started Bundles for New Customers
First-time buyers benefit from our progression bundles designed to support your Mounjaro journey. The Intro Duo (2.5mg + 5mg pens) costs £299.99 with first order discount - a £40 saving on the regular £339.99 price. Progress Duo (5mg + 7.5mg) £369.99 first order price, and Advance Duo (7.5mg + 10mg) £449.99 for new customers. These bundles ensure smooth dose progression as recommended by your prescriber.
How to Claim Your £40 New Customer Discount
Claiming your first order discount is simple. Add your chosen Mounjaro dose to basket, enter code FIRST40 at checkout, and complete our clinical consultation. Our qualified prescribers will assess your suitability for this prescription-only treatment within 3 working days (express 24-hour service available). Once approved, your genuine Mounjaro injection is dispatched discreetly with tracked delivery. No subscription commitments - order when you need your next prescription.
Complete First-Time Buyer Support
Your first Mounjaro order includes comprehensive support to ensure treatment success. Detailed injection guidance, dose progression advice, and lifestyle recommendations are provided with every prescription. Our clinical team explains how tirzepatide works by activating GIP and GLP-1 receptors to support appetite regulation alongside your reduced-calorie diet and increased physical activity programme. Questions during treatment? Our qualified pharmacists provide ongoing support throughout your Mounjaro journey.
